Marshall Wace, LLP Zoetis Inc. Transaction History
Marshall Wace, LLP
- $78.4 Billion
- Q4 2024
A detailed history of Marshall Wace, LLP transactions in Zoetis Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 788,429 shares of ZTS stock, worth $127 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
788,429
Previous 812,727
2.99%
Holding current value
$127 Million
Previous $159 Million
19.1%
% of portfolio
0.16%
Previous 0.21%
Shares
29 transactions
Others Institutions Holding ZTS
# of Institutions
2,053Shares Held
419MCall Options Held
1.22MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA41.4MShares$6.64 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$5.91 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.18 Billion0.13% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.57 Billion2.4% of portfolio
-
Morgan Stanley New York, NY11.8MShares$1.9 Billion0.14% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $75.1B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...